O4-02-06: ORAL TREATMENT WITH RD2 REDUCES Aβ OLIGOMER...

Alzheimer's & Dementia 2019 / 07 Vol. 15

O4-02-06: ORAL TREATMENT WITH RD2 REDUCES Aβ OLIGOMER LOAD, ENHANCES COGNITION, DECELERATES NEURODEGENERATION, REVERSES DISEASE PHENOTYPE IN OLD-AGED TG AD MICE, AND IS SAFE IN HUMANS

Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2019.06.4751
Date:
July, 2019
File:
PDF, 268 KB
2019
Conversion to is in progress
Conversion to is failed